Stay updated with breaking news from Drug Master. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
On February 12, the FDA issued a final rule regarding the use of Drug Master Files ("DMF") in Biologics License Applications.
Creative Medical Technology Holdings, Inc. (NASDAQ: CELZ) has recently seen a substantial intraday gain of over 15% in its share price. Despite the absence of any recent news or filings, this surge could suggest significant progress in the realm of allogeneic cell therapy. Background: The company is known for its regenerative approaches in various medical
What Is Allogeneic Cell Therapy, And What’s Driving This Market’s 25%+ ...
Biotechnology company Creative Medical Technology Holdings, Inc. (NASDAQ: CELZ) seems to be witnessing success in the allogeneic cell therapy market.
Operator: Good morning and thank you for joining the HOOKIPA Pharma Fourth Quarter and Full Year 2022 Earnings and 2022 Outlook Conference Call.